Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Canada Pension Plan Investment Board (CPPIB) announced today a R$ 500 million (C$175 million) equity target for a 20% interest in the newly established...
-
Tous les montants sont exprimés en dollars canadiens, sauf indication contraire. Voici les faits saillants : Rendement annuel net de 11,6 pour cent Hausse des actifs de 39,4 milliards de dollars,...
-
All figures in Canadian dollars unless otherwise noted. Highlights include: Net annual return of 11.6% Assets increase by $39.4 billion second largest annual growth since inceptionInvestment...
-
TORONTO and SINGAPORE, May 09, 2018 (GLOBE NEWSWIRE) -- Canada Pension Plan Investment Board (“CPPIB”) and GIC have entered into a joint venture partnership to acquire a Grade A office building in...
-
24 april 2018 Akzo Nobel N.V. publiceert resultaten 1e kwartaal 2018 (AKZA; AKZOY) AkzoNobel (Paints en Coatings): Tweesporenbeleid voor Specialty Chemicals met succes voltooid; ...
-
April 24, 2018 Akzo Nobel N.V. publishes results for the first quarter 2018 (AKZA; AKZOY) AkzoNobel (Paints and Coatings): Successfully completed the dual-track process for the separation...
-
LONDON and AUSTIN, Texas and PARIS, March 29, 2018 (GLOBE NEWSWIRE) -- Blue Prism (AIM:PRSM), the provider of the world’s most successful digital workforce, today announced the opening of a new...
-
27 maart 2018 Overeenkomst beëindigt het succesvolle tweesporenbeleid voor afsplitsing Akzo Nobel N.V. (AKZA; AKZOY) Belangrijke mijlpaal om een...
-
March 27, 2018 Agreement successfully concludes dual-track process Akzo Nobel N.V. (AKZA; AKZOY) Key milestone in creating a focused, high performing Paints and Coatings company Unleashing...
-
HONG KONG and SHANGHAI, China, March 26, 2018 (GLOBE NEWSWIRE) -- Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes, announced...